Connect Biopharma Holdings (CNTB) Cash from Operations (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Cash from Operations of 16005000.0 for Q1 2026, down 60.71% year-on-year from 40734422.44 in Q1 2025, and down 42.27% on a QoQ basis from 11250000.0 in Q4 2025.
Connect Biopharma Holdings (CNTB) Cash from Operations (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Cash from Operations for 3 consecutive years, with 16005000.0 the latest figure, recorded in Q1 2026.
- Quarterly Cash from Operations fell 60.71% year-over-year to 16005000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 57252000.0 (down 73.6% YoY) and the FY2025 annual result came in at 51206000.0, down 116.86% from the prior year.
- Cash from Operations fell to 16005000.0 in Q1 2026 per CNTB's latest filing, from 11250000.0 in the prior quarter.
- Over the last five years, Cash from Operations for CNTB reached as high as 591000.0 in Q1 2024 and fell as low as 17406000.0 in Q3 2025.
- A 3-year average of 10091444.44 and a median of 11250000.0 in 2025 frame the typical range for Cash from Operations.
- The largest YoY upside for Cash from Operations was 33.82% in 2025 against a maximum downside of 1585.11% in 2025.
- Year by year, Cash from Operations stood at 2319000.0 in 2024, then slumped by 385.12% to 11250000.0 in 2025, then slumped by 42.27% to 16005000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 16005000.0, 11250000.0, and 17406000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | -16.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.01 Mn |
| Mar 31, 2026 | -16.01 Mn |
| Dec 31, 2025 | -11.25 Mn |
| Dec 31, 2025 | -11.25 Mn |
| Sep 30, 2025 | -17.41 Mn |
| Sep 30, 2025 | -17.41 Mn |
| Jun 30, 2025 | -12.59 Mn |
| Jun 30, 2025 | -12.59 Mn |
| Mar 31, 2025 | -9.96 Mn |
| Mar 31, 2025 | -9.96 Mn |
| Dec 31, 2024 | -2.32 Mn |
| Dec 31, 2024 | -2.32 Mn |
| Sep 30, 2024 | -13.01 Mn |
| Sep 30, 2024 | -13.01 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Mar 31, 2024 | -591,000.00 |
| Mar 31, 2024 | -591,000.00 |